Imaging Cancer Metabolism with Positron Emission Tomography (PET)

Timothy H Witney, David Y Lewis

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
365 Downloads (Pure)

Abstract

Positron emission tomography (PET) enables the noninvasive spatiotemporal analysis of cancer metabolism in vivo. Both natural and nonnatural PET tracers have been developed to assess metabolic pathways during tumorigenesis, cancer progression, and metastasis. Here we describe the dynamic in vivo PET/CT imaging of the glucose analogue [18F]fluoro-2-deoxy-D-glucose (FDG), taking into consideration the methodology for alternative metabolic PET substrates.

Original languageEnglish
Pages (from-to)29-44
Number of pages16
JournalMethods in molecular biology (Clifton, N.J.)
Volume1928
Early online date7 Feb 2019
DOIs
Publication statusPublished - 2019

Fingerprint

Dive into the research topics of 'Imaging Cancer Metabolism with Positron Emission Tomography (PET)'. Together they form a unique fingerprint.

Cite this